{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:12:11Z","timestamp":1761156731055,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jneuroim.2019.577028","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:00:08Z","timestamp":1566525608000},"page":"577028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Successful combined treatment with thymectomy, rituximab and tocilizumab for severe thymoma-associated multi autoimmune syndrome"],"prefix":"10.1016","volume":"336","author":[{"given":"Olafur","family":"Sveinsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar","family":"Aspegren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max Albert","family":"Hietala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2019.577028_bb0005","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/WNL.0000000000002945","article-title":"Multiple sequential antibody-associated syndromes with a recurrent mutated neuroblastoma","volume":"87","author":"Amini","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2019.577028_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ane.12927","article-title":"Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barr\u00e9 syndrome: a pilot study","volume":"138","author":"Axelsson","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0015","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/1346-8138.13777","article-title":"Thymoma-associated multi-organ autoimmunity: a case of graft-versus-host disease-like erythroderma complicated by Good syndrome successfully treated by thymectomy","volume":"44","author":"Fukushima","year":"2017","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13311-015-0410-6","article-title":"Antibody-mediated autoimmune encephalopathies and immunotherapies","volume":"13","author":"Gastadli","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2019.577028_bb0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nmd.2017.03.007","article-title":"Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab","volume":"27","author":"Jonsson","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00000478-199502000-00011","article-title":"Graft-versus-host-like colitis associated with malignant thymoma","volume":"19","author":"Kornacki","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0035","first-page":"193","article-title":"Concurrent Guillain-Barr\u00e9 syndrome and myasthenia gravis: the first case in Taiwan","volume":"18","author":"Kung","year":"2009","journal-title":"Acta Neurol. Taiwanica"},{"key":"10.1016\/j.jneuroim.2019.577028_bb0040","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies","volume":"12","author":"Kuwabara","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2007.08.010","article-title":"Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?","volume":"114","author":"Offerhaus","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0050","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0003-4975(01)03505-6","article-title":"Graft-versus-host disease type colitis: an unusual association of malignant thymoma","volume":"73","author":"Sader","year":"2002","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0055","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3389\/fimmu.2019.01413","article-title":"Thymoma-associated paraneoplastic autoimmune multiorgan syndrome\u2014from pemphigus to lichenoid dermatitis","volume":"10","author":"Solimani","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2017.08.011","article-title":"Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis","volume":"312","author":"Sveinsson","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2018","key":"10.1016\/j.jneuroim.2019.577028_bb0070","first-page":"232076","article-title":"A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as add-on therapy for neuromyelitis optica spectrum disorder (NMOSD)","volume":"Oct 12","author":"Yamamura","year":"2018","journal-title":"ECTRIMS Online Libr."},{"key":"10.1016\/j.jneuroim.2019.577028_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281930339X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281930339X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:53Z","timestamp":1759048433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281930339X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"alternative-id":["S016557281930339X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577028","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful combined treatment with thymectomy, rituximab and tocilizumab for severe thymoma-associated multi autoimmune syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577028"}}